Versant Capital Management »

Mineralys Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Mineralys Therapeutics

Jul 2023Oct 2023Jan 2024Apr 2024Jul 2024Oct 2024Jan 202560070080030405060
Value ($)Share countHistorical MLYS position of Versant Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $652 53 12.30
2024-09-30 $762 63 12.11
2024-06-30 $736 63 11.70
2024-03-31 $813 63 12.90
2023-12-31 $542 63 8.60
2023-06-30 $546 32 17.06

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Microsoft Stock (MSFT)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vaneck Gold Miners Etf Etf (GDX)
Vanguard Total Stk Mkt Etf (VTI)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Exxon Mobil Corp Stock (XOM)
Apple Stock (AAPL)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Spdr Gold Minishares Trust Etf (GLDM)

View all positions for Versant Capital Management

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
Sr One Capital Management
Franklin Resources
OrbiMed Advisors
Vanguard Group
Laurion Capital Management
Adams Street Partners
Millennium Management
Jennison Associates
Caligan Partners
Integral Health Asset Management

View all funds holding Mineralys Therapeutics